DUPONT CAPITAL MANAGEMENT CORP - ISIS PHARMACEUTICALS INC ownership

ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 321 filers reported holding ISIS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
DUPONT CAPITAL MANAGEMENT CORP ownership history of ISIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2015$1,144,000
-19.3%
19,887
-10.6%
0.02%
-10.7%
Q1 2015$1,417,000
+15.4%
22,257
+11.9%
0.03%
+21.7%
Q4 2014$1,228,000
+12.0%
19,887
-29.6%
0.02%
+21.1%
Q3 2014$1,096,000
+12.6%
28,2370.0%0.02%
+18.8%
Q2 2014$973,000
-20.2%
28,2370.0%0.02%
-20.0%
Q1 2014$1,220,000
+8.4%
28,2370.0%0.02%0.0%
Q4 2013$1,125,00028,2370.02%
Other shareholders
ISIS PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
BB BIOTECH AG 6,634,838$268,180,0008.50%
DOWLING & YAHNKE LLC 676,379$27,339,0003.72%
WILLIAM HARRIS INVESTORS INC 317,301$12,826,0003.63%
Opus Point Partners Management, LLC 101,401$4,099,0002.26%
SOUND ENERGY PARTNERS, INC. 25,000$1,011,0002.04%
Sonora Investment Management, LLC 127,104$6,622,0002.00%
PINNACLE ASSOCIATES LTD 1,778,325$71,880,0001.59%
MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ 17,000$687,0001.36%
Apex Capital Management 1,019,618$41,213,0000.93%
PERKINS CAPITAL MANAGEMENT INC 20,350$823,0000.92%
View complete list of ISIS PHARMACEUTICALS INC shareholders